Literature DB >> 21335940

A comparison of suprapubic and transurethral catheterization on postoperative urinary retention after vaginal prolapse repair: a randomized controlled trial.

Eva Stekkinger1, Paul J Q van der Linden.   

Abstract

AIM: To compare the effect of suprapubic and transurethral catheterization on postvoid residual volumes (PRVs) after cystocele repair.
METHODS: 126 women who underwent pelvic organ prolapse surgery including cystocele repair were randomized to suprapubic or transurethral catheterization. At the third postoperative day, PRVs were measured. The number of women with PRV >150 ml, need for prolonged catheterization, recatheterization, length of hospital stay, frequency of urinary tract infections and complications were determined.
RESULTS: PRVs exceeded 150 ml in 13 out of 64 (20%) and 14 out of 62 (23%) women in the suprapubic and transurethral group, respectively (p = 0.76). In the suprapubic group a higher rate of urine leakage was noted (27 vs. 7%, p = 0.003). 10 women (16%) allocated to the suprapubic group switched to transurethral catheterization, because of problems with the suprapubic catheter. No protocol deviations were reported in the transurethral group. Of the women in both groups, 9% developed urinary tract infections (p = 0.93).
CONCLUSIONS: Suprapubic catheterization was comparable to transurethral catheterization in the prevention of postoperative voiding dysfunction after vaginal prolapse surgery, but it was associated with a higher rate of complications.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21335940     DOI: 10.1159/000323827

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  7 in total

Review 1.  Pelvic organ prolapse surgery and bladder function.

Authors:  Kaven Baessler; Christopher Maher
Journal:  Int Urogynecol J       Date:  2013-11       Impact factor: 2.894

2.  The incidence of urinary tract infection of different routes of catheterization following gynecologic surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Meixuan Li; Liang Yao; Caiwen Han; Huijuan Li; Yangqin Xun; Peijing Yan; Meng Wang; Wenbo He; Cuncun Lu; Kehu Yang
Journal:  Int Urogynecol J       Date:  2018-10-29       Impact factor: 2.894

Review 3.  Catheter-Associated Urinary Tract Infections in Adult Patients.

Authors:  Jennifer Kranz; Stefanie Schmidt; Florian Wagenlehner; Laila Schneidewind
Journal:  Dtsch Arztebl Int       Date:  2020-02-07       Impact factor: 5.594

4.  Suprapubic versus transurethral bladder drainage following reconstructive pelvic surgery: a comparison of patient satisfaction and quality of life.

Authors:  Michelle M Takase-Sanchez; Jennifer C Thompson; Douglass S Hale; Michael H Heit
Journal:  Int Urogynecol J       Date:  2016-10-06       Impact factor: 2.894

5.  Randomized controlled trial of silver-alloy-impregnated suprapubic catheters versus standard suprapubic catheters in assessing urinary tract infection rates in urogynecology patients.

Authors:  Ruchira Singh; Erik D Hokenstad; Sheila R Wiest; Shunaha Kim-Fine; Amy L Weaver; Michaela E McGree; Christopher J Klingele; Emanuel C Trabuco; John B Gebhart
Journal:  Int Urogynecol J       Date:  2018-08-25       Impact factor: 2.894

6.  Vaginal prolapse repair with or without a midurethral sling in women with genital prolapse and occult stress urinary incontinence: a randomized trial.

Authors:  J Marinus van der Ploeg; Katrien Oude Rengerink; Annemarie van der Steen; Jules H Schagen van Leeuwen; C Huub van der Vaart; Jan-Paul W R Roovers
Journal:  Int Urogynecol J       Date:  2016-01-06       Impact factor: 2.894

7.  A systematic review of outcome and outcome-measure reporting in randomised trials evaluating surgical interventions for anterior-compartment vaginal prolapse: a call to action to develop a core outcome set.

Authors:  Constantin M Durnea; Vasilios Pergialiotis; James M N Duffy; Lina Bergstrom; Abdullatif Elfituri; Stergios K Doumouchtsis
Journal:  Int Urogynecol J       Date:  2018-10-22       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.